MICHELLE ROBERTSON

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Daniel Calkins, Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MICHELLE ROBERTSON:

Company Role Class Num Shares Value Price $ Report Date Ownership
Editas Medicine, Inc. EVP, CHIEF FINANCIAL OFFICER Common Stock 106,610 $1,161,750 $10.90 11 May 2023 Direct
GERON CORP EVP, Chief Financial Officer Restricted Stock Units 110,000 $501,270 $4.56 18 Feb 2025 Direct
Verastem, Inc. Director Common Stock 16,666 $116,495 $6.99 22 May 2025 Direct
GERON CORP EVP, Chief Financial Officer Stock Option (right to buy) 656,000 18 Feb 2025 Direct
Editas Medicine, Inc. EVP, CHIEF FINANCIAL OFFICER Stock Option (right to buy) 94,500 02 Mar 2023 Direct
Verastem, Inc. Director Stock Option (right to buy) 12,500 22 May 2025 Direct

Insider Reports Filed by MICHELLE ROBERTSON

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VSTM Verastem, Inc. 22 May 2025 2 $0 4 Director 27 May 2025, 17:52
GERN GERON CORP 18 Feb 2025 2 $0 4 EVP, Chief Financial Officer 20 Feb 2025, 16:05
VSTM Verastem, Inc. 18 Jun 2024 2 $0 4 Director 20 Jun 2024, 20:31
GERN GERON CORP 06 Jun 2024 1 $0 4 EVP, Chief Financial Officer 07 Jun 2024, 16:10
VSTM Verastem, Inc. 11 Mar 2024 2 $0 4 Director 13 Mar 2024, 18:10
GERN GERON CORP 14 Feb 2024 1 $0 4 EVP, CHIEF FINANCIAL OFFICER 16 Feb 2024, 16:08
GERN GERON CORP 25 Sep 2023 1 $0 4 EVP, Chief Financial Officer 27 Sep 2023, 20:31
GERN GERON CORP 25 Sep 2023 0 $0 3 EVP, Chief Financial Officer 27 Sep 2023, 20:31
VSTM Verastem, Inc. 15 May 2023 1 $0 4 Director 16 May 2023, 16:32
EDIT Editas Medicine, Inc. 11 May 2023 1 -$9,369 4 EVP, CHIEF FINANCIAL OFFICER 15 May 2023, 16:30
EDIT Editas Medicine, Inc. 02 Mar 2023 3 -$1,636 4 EVP, CHIEF FINANCIAL OFFICER 06 Mar 2023, 15:30
EDIT Editas Medicine, Inc. 13 Feb 2023 1 -$41,435 4 EVP, CHIEF FINANCIAL OFFICER 15 Feb 2023, 15:30
EDIT Editas Medicine, Inc. 10 Jan 2023 1 -$14,296 4 EVP, CHIEF FINANCIAL OFFICER 12 Jan 2023, 15:30
EDIT Editas Medicine, Inc. 05 Dec 2022 1 -$1,974 4 EVP, CHIEF FINANCIAL OFFICER 06 Dec 2022, 15:30
EDIT Editas Medicine, Inc. 06 Sep 2022 1 -$2,882 4 EVP, CHIEF FINANCIAL OFFICER 08 Sep 2022, 16:30
VSTM Verastem, Inc. 22 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:09
EDIT Editas Medicine, Inc. 03 Jun 2022 1 -$17,617 4 EVP, CHIEF FINANCIAL OFFICER 06 Jun 2022, 16:45
VSTM Verastem, Inc. 12 May 2022 1 $0 4/A Director 20 Dec 2022, 15:08
EDIT Editas Medicine, Inc. 03 Mar 2022 1 -$13,290 4 EVP, CHIEF FINANCIAL OFFICER 07 Mar 2022, 15:15
EDIT Editas Medicine, Inc. 10 Feb 2022 2 $0 4 CHIEF FINANCIAL OFFICER 11 Feb 2022, 15:20
EDIT Editas Medicine, Inc. 11 Jan 2022 1 -$44,821 4 Chief Financial Officer 13 Jan 2022, 15:17
EDIT Editas Medicine, Inc. 22 Dec 2021 1 $0 4 Chief Financial Officer 23 Dec 2021, 15:09
VSTM Verastem, Inc. 15 Nov 2021 1 $0 4 Director 17 Nov 2021, 05:10
VSTM Verastem, Inc. 15 Nov 2021 0 $0 3 Director 17 Nov 2021, 05:03
EDIT Editas Medicine, Inc. 09 Aug 2021 3 -$73,375 4 Chief Financial Officer 10 Aug 2021, 16:33
EDIT Editas Medicine, Inc. 28 Jun 2021 3 -$48,375 4 Chief Financial Officer 30 Jun 2021, 16:11